http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
N-Butyl-N-(4-hydroxybutyl) Nitrosamine에 의해 유발된 흰쥐 방광암에서 Keyhole Limpet Hemocyanin의 항암 효과
선인철,김세웅,강성학 대한비뇨의학회 2004 Investigative and Clinical Urology Vol.45 No.8
Purpose: The antitumor activity and toxicity of keyhole limpet hemocyanin (KLH) on bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) were investigated. Materials and Methods: Sixty 6 to 8-week-old female C3H2 mice were divided into three groups. Bladder carcinomas were induced by the addition of 0.05% BBN to the drinking water for 8 weeks. Group A received an intravesical instillation of 0.25ml KLH-free buffer, Group B received 0.5mg KLH in 0.1ml buffer subcutaneously and Group C received an intravesical instillation of 2mg KLH in 0.25ml buffer twice weekly for 8 weeks(day 15 to day 70). On day 91, all the animals were sacrificed. The tumor incidence, bladder weight and toxicity were evaluated. Results: The incidences of cancer in groups A, B and C were 80, 40 and 60%, respectively. The incidence of cancer was significantly reduced in group B compared to group A(p<0.05). The average bladder weights were 93.63±17.746, 71.5±7.540 and 77.5±9.530mg in groups A, B and C, respectively. The bladder weights in groups B and C were significantly reduced compared to group A(p<0.05). There was no liver, kidney or bone marrow toxicities in groups B and C. Conclusions: These results suggest that KLH act as an effective and safe immunotherapeutic agent for bladder cancer. Prospective randomized clinical trials should be used to evaluate the role of KLH as an immunotherapeutic agent in the prophylaxis of recurrent bladder cancer. (Korean J Urol 2004;45:823-827)